10x Genomics, Inc. (TXG)
Largest Insider Buys in Sector
TXG Stock Price History Chart
TXG Stock Performance
About 10x Genomics, Inc.
10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumables products. Its single cell solutions runs on its chromium instruments, which include single cell gene expression for measuring gene activity on a cell-by-cell basis; single cell immune profiling for measuring the activity of immune cells and their targets; single cell Assay for Transposase Accessible Chromati (ATAC) for measuring epigenetics comprising the physical organization of DNA; and single cell multiome ATAC + gene expression for measuring the genetic activity and epigenetic programming in the same cells across tens of thousands of cells in a single experiment. The company also provides visium spatial gene expression solution for measuring spatial gene expression patterns across a single tissue sample or gene expression and protein co-detection when combined with immunofluorescence. It serves various academic, government, biopharmaceutical, biotechnology, and other institutions. The company was formerly known as 10X Technologies, Inc. and changed its name to 10x Genomics, Inc. in November 2014. 10x Genomics, Inc. was incorporated in 2012 and is headquartered in Pleasanton, California.
Insider Activity of 10x Genomics, Inc.
Over the last 12 months, insiders at 10x Genomics, Inc. have bought $0 and sold $1.8M worth of 10x Genomics, Inc. stock.
On average, over the past 5 years, insiders at 10x Genomics, Inc. have bought $12,793 and sold $283.6M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 158 shares for transaction amount of $6,397 was made by McAnear Justin J. (Chief Financial Officer) on 2022‑05‑13.
List of Insider Buy and Sell Transactions, 10x Genomics, Inc.
| 2024-11-22 | Sale | Chief Executive Officer | 6,693 0.0052% | $13.69 | $91,612 | +6.92% | ||
| 2024-11-22 | Sale | See Remarks | 5,807 0.0045% | $13.69 | $79,485 | +6.92% | ||
| 2024-08-22 | Sale | Chief Executive Officer | 6,749 0.0057% | $22.53 | $152,053 | -27.96% | ||
| 2024-08-22 | Sale | See Remarks | 4,351 0.0037% | $22.53 | $98,027 | -27.96% | ||
| 2024-08-22 | Sale | Former Chief Financial Officer | 2,961 0.0025% | $22.53 | $66,710 | -27.96% | ||
| 2024-05-22 | Sale | Chief Executive Officer | 4,877 0.0041% | $24.30 | $118,529 | -18.47% | ||
| 2024-05-22 | Sale | See Remarks | 4,087 0.0034% | $24.30 | $99,329 | -18.47% | ||
| 2024-05-22 | Sale | Chief Financial Officer | 2,936 0.0025% | $24.30 | $71,355 | -18.47% | ||
| 2024-03-04 | Sale | Chief Executive Officer | 4,660 0.0038% | $44.00 | $205,021 | -51.73% | ||
| 2024-02-22 | Sale | Chief Executive Officer | 2,821 0.0028% | $46.34 | $130,737 | -51.54% | ||
| 2024-02-22 | Sale | See Remarks | 2,613 0.0026% | $46.34 | $121,098 | -51.54% | ||
| 2024-02-22 | Sale | Chief Financial Officer | 1,865 0.0018% | $46.34 | $86,432 | -51.54% | ||
| 2024-02-15 | Sale | Chief Executive Officer | 5,000 0.0043% | $48.87 | $244,332 | -53.86% | ||
| 2024-02-09 | Sale | Chief Executive Officer | 1,000 0.001% | $49.53 | $49,530 | -55.21% | ||
| 2024-01-16 | Sale | Chief Executive Officer | 4,000 0.0034% | $45.24 | $180,956 | -49.42% | ||
| 2023-12-14 | Sale | Chief Executive Officer | 2,000 0.0017% | $55.03 | $110,065 | -56.85% | ||
| 2023-11-24 | Sale | Chief Executive Officer | 3,723 0.0032% | $43.72 | $162,751 | -37.86% | ||
| 2023-11-22 | Sale | Chief Executive Officer | 3,757 0.0032% | $43.34 | $162,816 | -37.74% | ||
| 2023-11-22 | Sale | See Remarks | 3,449 0.0029% | $43.34 | $149,468 | -37.74% | ||
| 2023-11-22 | Sale | Chief Financial Officer | 1,679 0.0014% | $43.34 | $72,762 | -37.74% |
Insider Historical Profitability
| Saxonov Serge | Chief Executive Officer | 872574 0.7208% | $15.00 | 0 | 57 | |
| Hindson Benjamin J. | See Remarks | 339897 0.2808% | $15.00 | 0 | 42 | |
| McAnear Justin J. | Former Chief Financial Officer | 143242 0.1183% | $15.00 | 1 | 38 | <0.0001% |
| Paladin Capital Management, LLC | 10 percent owner | 5617583 4.6405% | $15.00 | 0 | 2 | |
| Foresite Capital Management I, LLC | 10 percent owner | 2350000 1.9413% | $15.00 | 1 | 2 | +46.56% |
| ROBERTS BRYAN E | director | 1287825 1.0638% | $15.00 | 1 | 1 | +41.14% |
| Venrock Associates VI, L.P. | 10 percent owner | 1287825 1.0638% | $15.00 | 0 | 1 | |
| STUELPNAGEL JOHN R | director | 333736 0.2757% | $15.00 | 0 | 38 | |
| Mammen Mathai | director | 169745 0.1402% | $15.00 | 0 | 1 | |
| CRUTCHFIELD BRADFORD | Chief Commercial Officer | 97237 0.0803% | $15.00 | 1 | 31 | <0.0001% |
| Wilbur James | Chief Commercial Officer | 83342 0.0688% | $15.00 | 0 | 4 | |
| Kosaraju Sridhar | director | 3000 0.0025% | $15.00 | 0 | 10 |
Institutional Investor Ownership
| Fidelity Investments | $485.23M | 10.8 | 12.93M | +1.12% | +$5.39M | 0.03 | |
| The Vanguard Group | $341.58M | 7.6 | 9.1M | +1% | +$3.39M | 0.01 | |
| Baillie Gifford Co | $278.65M | 6.2 | 7.42M | -6.25% | -$18.59M | 0.22 | |
| ARK Investment Management LLC | $235.83M | 5.25 | 6.28M | +55.49% | +$84.16M | 0.82 | |
| BlackRock | $225.47M | 5.02 | 6.01M | +5.3% | +$11.34M | 0.01 | |
| Morgan Stanley | $193.82M | 4.31 | 5.16M | +23.57% | +$36.97M | 0.01 | |
| T. Rowe Price | $137.26M | 3.06 | 3.66M | +17.82% | +$20.76M | 0.02 | |
| Sumitomo Mitsui Trust Holdings | $135.93M | 3.03 | 3.62M | +58.6% | +$50.22M | 0.09 | |
| Nikko Asset Management Americas Inc | $135.78M | 3.03 | 3.62M | +58.6% | +$50.17M | 1.02 | |
| Sands Capital | $126.97M | 2.83 | 3.38M | -5.77% | -$7.77M | 0.36 | |
| Brown Capital Management | $100.39M | 2.23 | 2.67M | -24.17% | -$31.99M | 1.78 | |
| T Rowe Price Investment Management Inc | $82.73M | 1.84 | 2.2M | +93.19% | +$39.91M | 0.05 | |
| Venrock Management Vi Llc | $79.07M | 1.76 | 2.11M | 0% | +$0 | 100 | |
| Geode Capital Management | $61.68M | 1.37 | 1.64M | +3.48% | +$2.08M | 0.01 | |
| State Street | $59.51M | 1.33 | 1.59M | +1.7% | +$993,569.22 | <0.01 | |
| RTW Investments, LP | $58.35M | 1.3 | 1.55M | +0.32% | +$184,084.65 | 0.87 | |
| Credit Suisse | $54.66M | 1.22 | 1.46M | +16.5% | +$7.74M | 0.05 | |
| Boston Private Wealth Llc | $54.06M | 1.2 | 1.44M | -0.41% | -$224,879.80 | 1.17 | |
| Generation Investment Management Llp | $53.07M | 1.18 | 1.41M | -7.66% | -$4.4M | 0.24 | |
| Millennium Management LLC | $42.5M | 0.95 | 1.13M | +311.59% | +$32.17M | 0.03 | |
| Charles Schwab | $35.44M | 0.79 | 944,357 | +2.11% | +$732,773.25 | 0.01 | |
| Voloridge Investment Management, LLC | $33.84M | 0.75 | 901,745 | +68.01% | +$13.7M | 0.12 | |
| Franklin Templeton Investments | $33.07M | 0.74 | 881,164 | +67.02% | +$13.27M | 0.01 | |
| BNY Mellon | $31.93M | 0.71 | 850,815 | -10.19% | -$3.62M | 0.01 | |
| Capital World Investors | $29.77M | 0.66 | 793,300 | 0% | +$0 | 0.01 | |
| Freshford Capital Management Llc | $29.39M | 0.65 | 783,238 | +156.13% | +$17.92M | 5.14 | |
| Alyeska Investment Group L P | $26.51M | 0.59 | 706,492 | -0.33% | -$88,458.21 | 0.16 | |
| Southpoint Capital Advisors Lp | $26.27M | 0.59 | 700,000 | New | +$26.27M | 0.52 | |
| New York State Common Retirement Fund | $24.65M | 0.55 | 656,709 | +2.15% | +$517,682.75 | 0.03 | |
| Bank of America | $24.01M | 0.53 | 639,832 | +137.9% | +$13.92M | <0.01 | |
| Northern Trust | $22.21M | 0.49 | 591,862 | +26.03% | +$4.59M | <0.01 | |
| First Trust | $21.76M | 0.48 | 579,884 | +3,940.44% | +$21.22M | 0.02 | |
| Squarepoint Ops LLC | $19.15M | 0.43 | 510,163 | +113.12% | +$10.16M | 0.07 | |
| Granite Investment Partners Llc | $19.1M | 0.43 | 509,033 | New | +$19.1M | 0.73 | |
| Gilder Gagnon Howe & Co. LLC | $18.92M | 0.42 | 504,174 | +0.34% | +$63,913.59 | 0.24 | |
| Meritech Capital Associates V L L C | $18.55M | 0.41 | 494,236 | 0% | +$0 | 6.2 | |
| Sands Capital Ventures LLC | $18.08M | 0.4 | 481,770 | 0% | +$0 | 4.36 | |
| Dimensional Fund Advisors | $17.87M | 0.4 | 476,237 | -5.02% | -$944,892.78 | 0.01 | |
| Ameriprise Financial | $17.5M | 0.39 | 466,354 | -9.51% | -$1.84M | 0.01 | |
| Alger | $16.72M | 0.37 | 445,567 | +9.97% | +$1.52M | 0.08 | |
| Voya Investment Management LLC | $14.95M | 0.33 | 398,451 | +557.97% | +$12.68M | 0.02 | |
| Qube Research & Technologies | $14.4M | 0.32 | 383,704 | New | +$14.4M | 0.02 | |
| Td Asset Management Inc | $14.25M | 0.32 | 379,564 | +37.94% | +$3.92M | 0.01 | |
| Cubist Systematic Strategies | $13.71M | 0.31 | 365,322 | +196.13% | +$9.08M | 0.12 | |
| Trexquant Investment LP | $13.6M | 0.3 | 362,419 | +257.61% | +$9.8M | 0.24 | |
| Mirae Asset Global Investments Co Ltd | $15.61M | 0.27 | 319,287 | +264.52% | +$11.33M | 0.02 | |
| Bamco | $11.82M | 0.26 | 314,862 | +59.37% | +$4.4M | 0.03 | |
| Bellevue Group | $11.57M | 0.26 | 308,311 | +5.16% | +$568,129.15 | 0.18 | |
| Goldman Sachs | $10.74M | 0.24 | 286,146 | -23.26% | -$3.25M | <0.01 | |
| Nuveen | $9.47M | 0.21 | 252,300 | +0.28% | +$26,158.41 | <0.01 |